CompoAtlas

Prosolve

Prosolve, licence 80029558: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
BioAid Health Products Inc.
NPN or DIN-HM
80029558
Status
Active licence
Licence date
14 February 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Serenoa repens

Source : Baie(s)

Potency : 45.0 % fatty acid

200.0 mgNot calculated
Vitamine E

Source : Acétate de d-alpha tocophéryle

Potency : 10.0 UI

6.7 mg ATNot calculated

Non-medicinal ingredients

L-leucine, Hypromellose, Pullulane, Stéarate de magnésium, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinminimum: 19.0 Année(s)3.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Prosolve is formulated with herbs used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia (BPH).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80029558

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line